臨牀透析 Vol.30 No.6(2-8)


特集名 透析関連専門資格に求められるもの・これからの透析医療教育―現状と課題
題名 [各論/薬剤師]8. 腎臓病薬物療法専門(認定)薬剤師認定制度
発刊年月 2014年 06月
著者 平田 純生 熊本大学薬学部附属育薬フロンティアセンター・臨床薬理学分野/日本腎臓病薬物療法学会理事長
著者 木村 健 兵庫医科大学病院薬剤部/日本腎臓病薬物療法学会副理事長・専門薬剤師制度対策委員長
著者 竹内 裕紀 東京薬科大学薬学部医療実務薬学教室/日本腎臓病薬物療法学会副理事長・学術委員長,教育研修委員長
【 要旨 】 2013年に日本腎臓病薬物療法学会によって腎臓病薬物療法専門薬剤師14名,腎臓病薬物療法認定薬剤師45名が認定された.腎臓病薬物療法専門・認定薬剤師は薬学を基盤とした専門的な臨床能力を発揮することによって,腎機能に応じた適切な薬物療法の提供,ならびに薬剤性腎障害の回避や透析患者などで多発する中毒性副作用を未然に防ぐことが期待される.日本腎臓病薬物療法学会は関連学会と協力し,「腎臓病患者に配慮した有効かつ安全な最高の薬物療法を医師や他の医療スタッフと協力しながら責任もって提供できる薬剤師」を専門・認定薬剤師として育成する.
Theme Certification system for dialysis specialists ; its present status and future in Japan
Title Nephrology and pharmacotherapy specialist as well as Certified nephrology pharmacists.
Author Sumio Hirata President of the Japanese Society of Nephrology and Pharmacotherapy / Division of Clinical Pharmacology, Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University
Author Takeshi Kimura Vice-president and Chairperson of the Committee of Nephrology and Pharmacotherapy Specialist of the Japanese Society of Nephrology and Pharmacotherapy / Department of Pharmacy, the Hospital of Hyogo College of Medicine
Author Hironori Takeuchi Vice-president, Chairperson of Academic Committee, and Chairperson of Training and Development of the Japanese Society of Nephrology and Pharmacotherapy / Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences
[ Summary ] The Japanese Society of Nephrology and Pharmacotherapy (JSNP) certified 14 nephrology and pharmacotherapy specialists and 45 nephrology pharmacists in 2013. These specialist certified pharmacists are expected to fully utilize their clinical skills and have fundamental knowledge in pharmacy. They are expected to prevent drug-induced renal failure in patients with chronic kidney disease and prevent toxic side effects that frequently occur in dialysis patients. In cooperation with affiliated societies, the JSNP seeks to cultivate pharmacists who, in collaboration with primary care physicians and other medical professionals, will responsibly provide optimal drug therapy tailored to individual patients.
戻る